Industry Insight
Information, Observation & Analysis
As baby boomers age, rates of cancer diagnosis and survival increase, causing an increasing need for supportive oncology care.
Knowing the facts about shingles can help you to better protect yourself against it — and how to treat it if you get it.
Toxic shock syndrome remains a serious, life-threatening complication of certain types of infections that can be fatal.
Using nutrition to benefit health through the care and feeding of genes, though still in its infancy, is an exciting field of study seeing exponential growth.
Despite the many vaccine candidates undergoing clinical trials, experts doubt an effective vaccine for Alzheimer's disease is on the horizon.
Healthcare professionals who do not embrace AI will eventually find themselves out of touch with the industry.
New FcRn inhibitors may be a viable therapeutic option for certain patients currently treated withIG and plasma exchange.
To appreciate how the “Chinese economic miracle” has helped improve access in particular to advanced medical care, one need look no further than its utilization of a single product that is widely used in hospitals to treat severely ill intensive care unit and other patients. That product, now China’s highest dollar-value prescribed therapeutic, is human albumin.
Cardiovascular disease poses a significant risk for women, yet most women remain unaware mainly due to myths and misconceptions.
Recent disease trends among adolescents and young adults have fueled vaccine schedule updates. Many have been outbreak-driven; others reflect vaccine improvements and innovations. All are critical to improve the health.
Vaccine adherence rates for seniors are low, increasing health risks for this older population and beyond.
A growing body of evidence suggests known pharmacologic properties of human albumin may contribute to reducing the risk of a range of cirrhosis complications, including bacterial sepsis, irreversible renal injury and death.